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Abstract: Carotid bodies (CBs) are secondary sensory receptors in which the sensing 
elements, chemoreceptor cells, are activated by decreases in arterial PO2 (hypoxic 
hypoxia). Upon activation, chemoreceptor cells (also known as Type I and glomus cells) 
increase their rate of release of neurotransmitters that drive the sensory activity in the 
carotid sinus nerve (CSN) which ends in the brain stem where reflex responses are 
coordinated. When challenged with hypoxic hypoxia, the physiopathologically most 
relevant stimulus to the CBs, they are activated and initiate ventilatory and cardiocirculatory 
reflexes. Reflex increase in minute volume ventilation promotes CO2 removal from alveoli 
and a decrease in alveolar PCO2 ensues. Reduced alveolar PCO2 makes possible alveolar 
and arterial PO2 to increase minimizing the intensity of hypoxia. The ventilatory effect, in 
conjunction the cardiocirculatory components of the CB chemoreflex, tend to maintain an 
adequate supply of oxygen to the tissues. The CB has been the focus of attention since the 
discovery of its nature as a sensory organ by de Castro (1928) and the discovery of its 
function as the origin of ventilatory reflexes by Heymans group (1930). A great deal of 
effort has been focused on the study of the mechanisms involved in O2 detection. This 
review is devoted to this topic, mechanisms of oxygen sensing. Starting from a summary of 
the main theories evolving through the years, we will emphasize the nature and significance 
of the findings obtained with veratridine and tetrodotoxin (TTX) in the genesis of current 
models of O2-sensing.  
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1. Introduction: A Summary of Carotid Body (CB) General Function and Mechanisms up to the 
Mid-1980s 
The carotid bodies (CBs) were discovered towards the middle of eighteen century, and thought for 
many years to be a small ganglion of the vegetative or autonomic nervous system. Accordingly, the 
CB received the names of ganglium parvum, ganglium minutum, ganglium exiguum or gangliolum 
intercaroticum. Early in the second half of the nineteen century, the great German anatomist Hubert 
von Luschka redefined the apparent nature of the CB, and proposed that the CB was not a ganglium 
but an endocrine gland, that he named glandula intercarotica (readers interested in early historical 
aspects are referred to [1]). The great prestige of the German anatomist meant that the CB was 
considered to be an endocrine gland, glandula intercarotica or carotid gland to almost the middle of the 
twentieth century. In a brilliant study on the innervation of the CB, Fernando de Castro, a favorite 
disciple of Cajal, discovered that the CB was neither a ganglion nor a gland, but a sensory organ as it 
received sensory innervation via the carotid sinus nerve (CSN) from sensory neurons located in the 
sensory ganglion (the petrosal ganglion) of the IX cranial nerve (the glossopharyngeal). A few years 
later, Heymans and coworkers discovered the function of the CB as the origin of cardiorespiratory 
reflexes and was awarded the Nobel Prize in 1938 [2].We cite this exact quote in the note as our tribute 
of recognition to Fernando de Castro’s role in the discovery of arterial chemoreceptors; regrettably his 
contribution was not awarded.  
The CBs are small paired organs located in the vicinity of the carotid artery bifurcation, existing as 
minor anatomical variations between species and among individuals of the same species. It is 
commonly pear or cone-shaped with the apex cephalically oriented and the base resting on the carotid 
sinus or one of the large arteries of the region. It is surrounded by a thin capsule of loose connective 
tissue which contains a dense net of small veins, giving the organ a distinct reddish-pink appearance 
that facilitates its recognition. Occasionally with the naked eye, although quite frequently a dissecting 
microscope is needed, the entrance into the organ can be seen by its cephalic pole of a thin nerve, the 
carotid sinus nerve (CSN a branch of the glossopharyngeal or IX cranial nerve) which represents the 
sensory innervation of the CB. Somas of the CSN fibers are located in the petrosal ganglion, the 
sensory ganglion of the glossopharyngeal. A section of a well perfused CB allows us to distinguish its 
basic structure [3]: thin walls of connective tissue containing a dense net of capillaries and venules 
emerge from the external capsule and divide the CB interior in lobules. Each lobule houses a cluster of 
cells of two types: rounded or ovoid chemoreceptor cells (also known as type I or glomus cells) are 
located towards the center of the cluster and flatted disc-shaped substentacular cells (or type II) are 
located towards the periphery of clusters. With appropriate stains it is possible to see bundles of nerve 
fibers travelling in the connective tissue walls and penetrating the cell clusters to form polymorphic 
endings in close apposition to chemoreceptor cells, forming the “sensory synapse” of the CB. In 
ultrathin sections it is possible to see a dense population of dense-core vesicles, which represent the 
most conspicuous trait of chemoreceptor cells. These vesicles contain catecholamine (and ATP and 
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some neuropeptides) are commonly seen clustered facing sensory nerve endings. Chemoreceptor cells 
also contain clear-core vesicles that are thought to contain acetylcholine.  
The CB is a secondary sensory receptor in which the sensing elements, chemoreceptor cells, are 
activated by decreases in PO2 (hypoxic hypoxia) and increases in PCO2 and [H+] in arterial blood. The 
location of CBs in vicinity of the bifurcation of the common carotid artery has commonly been seen as 
if the CBs were tasting blood reaching the brain for possible correction of its composition. Upon 
activation, chemoreceptor cells increase their rate of release of neurotransmitters which drive the 
sensory activity in the CSN, which ends in the nucleus of tractus solitarius in the brainstem where the 
first synaptic station of the CB chemoreflex is located. Fibers from neurons located in the nucleus of 
the tractus solitarius project to several nuclei of the medulla and pons to ultimately generate the 
efferent orders of the chemoreflex. These efferent orders are directed to the motoneurons of the 
respiratory muscles and to sympathetic outflow neurons in the spinal cord to control the 
intensity/frequency of the respiratory movements and several cardiovascular parameters (heart 
frequency, vascular resistance, etc.) and adrenal medulla secretion of catecholamines (CA). Additional 
neural information entering brainstem from the CB ascends from the nucleus tractus solitarius to the 
hypothalamus to control the secretion of several hormones (ACTH-cortisol, vasopressin) whose 
plasma levels change during hypoxia and hypercapnia/acidosis; these hormones also contribute to the 
overall adaptive and homeostatic function of the CB [3–5]. The overall reflex responses originated in 
the CB are: an increase in lung ventilation in response to hypoxia and hypercapnia, bradycardia with 
increased cardiac output due to a positive inotropic effect and an increase in systemic blood pressure 
due to increases in resistance in most vascular beds, increase in the release of CA, adrenocorticotropic 
hormone-cortisol, antidiuretic hormone, and renin, and thereby angiotensin II. 
Even if the significance of the CB at the systemic level was reasonably well characterized by the 
middle of the second half of the past century, the cellular mechanisms operating in the CB, i.e., how 
chemoreceptor cells detect the stimuli (sensory transduction) and the synaptic mechanisms 
communicating chemoreceptor cells and the sensory nerve endings of the CSN, that is, the sensory 
neurotransmission mediating conducted electrogenesis in his secondary sensory receptor [6,7] 
remained unknown. In 1977, Gonzalez and Fidone [8] directly measured, for the first time, the release 
of catecholamines (CA), mostly dopamine (DA), by chemoreceptor cells of the rabbit CB when 
challenged with hypoxia. In successive studies [9,10], we firmly established that release of CA from 
chemoreceptor cells occurred in a close relationship with intensity of hypoxic and hypercapnic stimuli 
and in proportion to the action potential frequency in the CSN. Taking into account that petrosal 
ganglion neurons express catecholaminergic traits [11] and when cultured they release CA in response 
to several stimuli [12], it might be argued that our supposedly chemoreceptor cell CA release is 
“contaminated” by the release from intraglomic sensory nerve endings. Although such contribution 
exists, quantitatively speaking is so small that it is negligible: peak CA release obtained in response to 
supramaximal electrical stimulation of the carotid sinus nerve was 2.5 pmol/g CB tissue/5 min [13] 
and peak release in response to a hypoxic stimulus of intermediate intensity was 400 pmol/g CB 
tissue/5 min [9]. Additionally, a potential short-term acute modulation of chemoreceptor cells function 
by other neurotransmitters contained in the sensory nerve endings [4] was demonstrated [9], but the 
relationship between hypoxic stimulation and release was maintained in deafferented CBs. Overall, our 
observations on the release of CA from chemoreceptor cells drove our laboratory to focus the problem 
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of sensory transduction in these cells, not as a unique or unparalleled process (Figure 1), but rather as a 
common process occurring in a great variety of secretory cells and presynaptic nerve endings. In other 
words, we started to experimentally approach sensory transduction in the CB as a stimulus-secretion 
coupling process in the same manner that Douglas and Rubin [14,15] and Katz [16] did while working, 
respectively, in the secretion of CA in the adrenal medulla and in the neuromuscular junction.  
Figure 1. By the middle 1970s, the carotid body (CB) remained as a mystery. The theory 
most commonly accepted had been proposed by Anichkov and Belenkii in 1963 [17]. It 
was based on the observation that metabolic poisons, which were known to decrease ATP 
levels in cells, excited the CB increasing carotid sinus nerve (CSN) activity and eliciting 
brisk ventilatory responses. The reasoning was that hypoxia would act alike metabolic 
poisons, but no test was provided on whether mild hypoxia that excites the CB do in fact 
decrease ATP and no mechanisms were proposed as to how the ATP decrease would be 
coupled to the exocytosis of neurotransmitters [3].  
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Despite the notions of the uniqueness of the CB, the difficulty in studying this O2-CO2 sensing 
organ, and the also small chemoreceptor cells meant it pervaded the literature. For example, even if the 
early 1980s saw published works [8–10,18] demonstrating the calcium dependency of the release of 
CA elicited by natural stimuli, therefore conforming the stimulus-secretion coupling process, it was 
still undecided whether or not the membrane potential of chemoreceptor cells was dependent on  
K+ ion. In a seminal paper from our laboratory in 1986 by Almaraz et al. [19] it was concluded: “…our 
study shows that high extracellular K+ evokes a Ca2+-dependent secretory response in chemoreceptor 
cells with a threshold and dose-response expression not different from that obtained in a variety of 
structures where high K+ has been shown to depolarize their membrane. This suggests that the 
membrane potential of type I cells is dependent on the extracellular concentration of this ion. The 
secretory response also follows the general Ca2+ theory of neurosecretion. Finally…the fact that 
natural stimuli for the CB chemoreceptors elicit a release of DA which also is Ca2+ dependent makes it 
of interest to further characterize Ca2+ conductances involved in the secretory response”.  
Another finding indicating that hypoxia depolarized chemoreceptor cells was the increase of 
glucose consumption in the CB induced by hypoxia (the natural stimulus to chemoreceptor cells) of 
low intensity. This increase was tissue specific and ouabain sensitive [20–22], implying was that 
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hypoxia should depolarize chemoreceptor cells and that depolarization would, at least in part, due to 
Na+ entry into the cells [23]; Na+ entering would activate the Na+/K+-dependent ATPase and thereby 
explain the sensitivity of the increased glucose consumption to ouabain. In other words, if the data 
with K+ suggested that hypoxia should depolarize to activate the voltage dependent Ca2+ channels, the 
metabolic data suggested the involvement of Na+ channels in the depolarization process. Before 
presenting how we dealt with investigation of depolarization and definition of pathways for Ca2+ entry 
in this precise historical manner we will make a parenthesis to present the tools used: veratridine and 
tetrodotoxin and dihydropyridine. 
2. The Tools: Veratridine and Tetrodotoxin (TTX), and Ca2+ Antagonists (Dihydropyridines) 
We knew from the studies carried out in many endocrine glands, in particular the adrenal  
medulla [24] and in motor nerve endings that well respected scientists have been routinely using 
veratridine and TTX. The more recently introduced calcium channel antagonists, in particular of the 
dihydropyridine family, entered into play in the neurotransmission-hormone secretion fields a few 
years later [25]. 
In his vast review of 1974 [26], Narahashi described the following traits for veratridine (an alkaloid 
derived from the family of Liliaceae): (1) its use in the study of excitable membranes has been limited, 
partly because its mechanism of action still remains to be fully elucidated. (2) It depolarizes through a 
change in a transient conductance and a selective increase in resting sodium permeability. (3) Its 
depolarizing action is eliminated in the absence of sodium and is antagonized by TTX. (4) Like high 
external K+ it promotes accumulation of calcium and release of neurotransmitters in synaptosomes, but 
while the effects of veratridine are blocked by TTX those of high K+ are not. (5) The association between 
calcium entry and neurotransmitter release induced by veratridine conforms the stimulus-secretion 
mechanism. In the 1984 edition of Hille’s book [27] there were no additional hints as to the 
mechanism of action of veratridine, but neurochemists and pharmacologists were enlarging the body of 
information regarding the effects of veratridine and its usefulness to study the stimulus-coupling 
process. For example, the studies by Kirpekar and co-workers [28] extended to isolated chromaffin 
cells and hypogastric nerve the initial observations on the release process induced by veratridine. 
Kirsnher laboratory working with isolated chromaffin cells used profusely veratridine in the experiments 
that allowed him to create the concepts of vesicular-quantal release of CA and of co-storage of 
classical neurotransmitters and neuropetides [29,30]. Kirshner laboratory generated a body of doctrine 
regarding veratridine action on neurosecretion that continues to be valid nowadays. On the biophysical 
side, the use of electrophysiological recordings, the measurements of ion fluxes, and the binding 
techniques [31,32] drove the knowledge regarding molecular mechanism of action of veratridine to 
levels overridden only when the explosion of molecular biology techniques appeared [33]. In any case, 
by the very early eighties it was firmly established that if in any given cell veratridine promotes a 
physiological response that is sodium-dependent and blocked by TTX, such a given cell possesses 
voltage-dependent Na+ channels. 
TTX name derives from Tetraodontiformes, the name of the order that includes among other the 
pufferfish which carries the toxin in its liver and other internal organs. In the above-mentioned review 
by Narahashi, it is attributed the discovery and naming of TTX in the modern era to Tahara, in  
1910 [34], although the same author had already presented some toxicological studies to the 
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Pharmaceutical Society of Japan in 1889. Half a century later, Narahashi et al. in 1960 [35] in an 
elegant study carried out in frog skeletal muscle fibers and using microelectrodes that concluded: from 
the observations of resting potential, action potential, membrane resistance, and delayed rectification, 
TTX blocks action potentials by a selective inhibition of the transient (sodium) conductance normally 
occurring upon depolarizing stimulation. This study and its conclusion was the pillar of our 
understanding on the mechanism of action of TTX. Studies by Narahashi and many other researchers 
in the most classical preparations (squid axons, frog skeletal muscle, neuromuscular junction of the 
frog, squid axon synapse, Ranvier node, etc.) had produced according to PubMed 1089 publications by 
the time the review by Narahashi appeared in 1974. In those early days in the use of TTX, so many 
basic aspects of physiology were discovered with the judicious use of TTX, that we cannot resist 
quoting some: (1) Loewenstein et al. [36] concluded: “evidence is presented that spike and transducer 
processes in sensory receptors are independent events; impulse activity in tile crustacean stretch 
receptor neuron and the mammalian paccinian corpuscle was selectively blocked by a compound 
(tetrodotoxin) without affecting any of the parameters of the generator potential”. (2) Hagiwara and 
Nakayima [37] concluded: “Tetrodotoxin, … has no effect on the calcium action potential … of frog 
cardiac ventricle, tetrodotoxin suppresses the rate of rise of the action potential without affecting the 
overshoot; the suppressive effect of manganese ion is mainly on the overshoot of the action potential. 
This suggests that, in the action potential of the cardiac ventricle of the frog, the plateau phase is 
related primarily to the increase in permeability of the membrane to calcium ions”. (3) Katsuki et al. [38] 
working on guinea pig cochlea concluded: “Tetraethylammonium chloride … believed to decrease 
potassium conductance, and tetrodotoxin, which apparently decreases sodium conductance …. The 
former depressed the direct-current endocochlear potential and also the alternating-current cochlear 
microphonics (the receptor potential of the ear), but tetrodotoxin was ineffective except on the nerve 
impulses”. (4) Nonomura et al. [39] concluded: “Tetrodotoxin … has no effect on the spontaneous 
discharge in the smooth muscle of taenia coli … [that was] abolished by Mn++. Because Mn++ is a 
specific suppressor of the spike induced by Ca++ and tetrodotoxin is an inhibitor of the spike induced 
by Na+, we suggest that Ca++ is a charge carrier in the production of spike potential in the smooth 
muscle and that the entry of intervening Ca++ through the membrane acts as a trigger for the 
contraction of smooth muscle”. 
In summary, before the arrival of the 1980s, the doctrine was firmly established: TTX is a very 
selective blocker of voltage-dependent Na+ channels that does not affect other ionic conductances and 
that has proven to be an extraordinary tool to establish many basic principles of physiology, including 
many aspects of stimulus secretion coupling and postsynaptic actions of neurotransmitters. But 
attaching to our interest in present article, the conclusion could be that the pufferfish toxin activity or 
efficacy to suppress the effects resulting from the stimulation of any cell type, whether physiologically 
or pharmacologically stimulated as with veratridine (but not depolarized by K+), was an univocal 
demonstration of the presence of voltage dependent sodium channel in the cell under study.  
Calcium antagonists [40] or “slow channel inhibitors” [41] were developed around the heart 
pathology, as potential treatments for heart ischemia or stroke and hypertension. In his early historical 
review of 1983, Fleckenstein [40] wrote that verapamil and prenylamine (both introduced in 1964), 
mimicked the cardiac effects of simple Ca++ withdrawal (they diminished Ca++-dependent ATP 
utilization, contractile force, and O2 requirement of the beating heart without affecting the Na+-dependent 
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parameters of the cardiac action potential), and that their effects could easily be distinguished from 
those of β-blockers with simple experimental tools. Other substances that met the criteria of calcium 
antagonists in those days included D-600 (introduced in 1968) and the dihydropyridines nifedipine, 
niludipine and nimodipine (made available along the 1970s). All of them, as well as diltiazem 
introduced by the Japanese, interfered with the uptake of labelled Ca++ into the myocardium and 
blocked excitation-contraction coupling of vascular smooth muscle. On the bases of voltage-clamp 
experiments the conclusion was reached that all these antagonists act as specific inhibitors of the slow 
trans sarcolemmal Ca++ influx. 
However, findings with the use of calcium antagonists or slow channel inhibitors or organic 
blockers of calcium channels up to 1984, remained inexplicably confusing because in some preparations 
(e.g., synaptosomes; see next paragraph) several laboratories reported that these drugs would not 
prevent depolarization 45Ca2+ uptake or and neurotransmitter release [42,43]. As a consequence, the 
preferred tools to investigate the role of Ca2+ in any process were extracellular Ca2+ removal or the use 
of other divalent cations (most frequently Mg2+ or Mn2+), inorganic blockers of calcium channels. In 
1983, a dihydropyridine agonist of calcium channel, BAY-K 8644, was introduced [44], and the 
combined use of BAY-K 8644 with the more classical dihydropyridine antagonists defined pairs of 
tools of enormous value to investigate the role of Ca2+ in the stimulus secretion coupling, both in 
endocrine and synaptic preparations. Quite soon two different laboratories using PC12 and native 
adrenomedullary chromaffin cells [25,45] used both agents alone or in combination and concluded that 
nitrendipine-nifedipine (and other Ca2+ antagonists) bind to Ca2+ channel and block the entry of Ca2+ 
into the cells abrogating Ca2+ dependent responses, Bay 8644 competes with the binding of the 
dihydropyridine antagonist, and when applied alone promotes Ca2+ entry and triggers Ca2+ dependent 
responses. The electrophysiological observations of Nilius [46] in cardiomyoctes sanctioned the 
neurochemical-pharmacological observations on secretory cells as he stated: “… novel dihydropyridine 
compound BAY-K 8644 … augments the maximum upstroke velocity Vmax of slow action potentials 
in concentrations between 2 × 10−9 and 2 × 10−7 mol/L …. The increase in Vmax could be antagonized 
by nifedipine in a similar range of concentrations …. At concentrations higher than 6 × 10−7 mol/L 
BAY-K produced oscillatory afterdepolarizations indicating a drug-induced Ca overload. All the 
experimental findings are consistent with the hypothesis that the novel dihydropyridine compound 
BAY-K 8644 activates Ca-channels in the mammalian ventricular myocardium”.  
Therefore, a nice pair of tools had certainly been defined, but findings in synaptosomes stubbornly 
kept producing results that quite frequently did not fit the notions expressed in preceding paragraph  
(e.g., [47] and the conclusion in many of these articles was: results suggest that synaptosomal  
voltage-sensitive Ca2+ channels either are of a different type to those found in peripheral tissues 
including heart and smooth muscle cells and peripheral cells of neural origin …. Another typical 
conclusion was: “findings suggest that high-affinity binding of nitrendipine is not directly linked to 
voltage-dependent calcium uptake in brain” or “data indicate that high-affinity Ca2+ channel antagonist 
and agonist (nitrendipine and BAY-K 8644) binding sites exist in synaptosomal membranes but their 
relationship to functional Ca2+ channels is not clear. In the famous review by Hagiwara and Byerly of 
1981 [48] unequivocal evidence was presented for the existence of different types of voltage 
dependent Ca2+ channels, even if the different subtypes of currents-channel have not been recorded in 
isolation. Tsien and coworkers in a series of articles between 1984–1986 summarized in  
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McCleskey et al. [49] provided the direct experimental evidence for the diversity of Ca2+ channels, so 
that a single cell type might have several of those subtypes of channels, and thereby gave explanation 
to the conflicting results with the dihydropyridine agonists and antagonists of Ca2+ channels in 
synaptosomal, and occasionally in peripheral, preparations. Specific tools to dissect most of the 
channel subtypes role in physiological processes were soon after provided by the laboratory of Olivera 
in Salt Lake City [50] as they isolated many specific toxins for each channel subtype from marine 
snails and spiders. The dissection of Ca2+ channel subtypes in rabbit chemoreceptor cells has recently 
been done by our laboratory [51]. In brief, using current pharmacological-electrophysiological criteria 
for classification of Ca2+ we found that adult rabbit chemoreceptor cells exhibit components of their 
Ca2+ currents that are sensitive to ω-conotoxin GVIA and to ω-agatoxin IVA as well as to nisoldipine, 
suggesting the presence, in addition to L-type, of N and P/Q type Ca2+ channels as well as a significant 
residual component of R-channels. Their contribution to release of CA elicited by hypoxia and is 
shown in Figure 2.  
Interestingly, the involvement of the different subtypes of Ca2+ channels in the  
hypoxia-induced substance P release appears to be different. Thus, Kim et al. [52] found that about 
85% of calcium dependent substance P release induced by hypoxia in the rabbit CB was inhibited by 
ω-conotoxin GVIA (an N-type Ca2+ channel blocker), while nitrendipine only inhibited the release by 
~65%, and ω-agatoxin TK (a P/Q-type Ca2+-channel inhibitor) had no significant effect.  
In summary, by the middle of decade of the 1980 we have available a great armamentarium of 
specific tools to study the ionic properties of the membrane of chemoreceptor cells and certainly to 
explore the transduction of natural stimuli of chemoreceptor cells, hypoxia and hypercapnia, when it is 
conceptually seen as a stimulus-secretion process.  
Figure 2. Relative contribution of different calcium channel subtypes to whole calcium 
current registered in primary cultures of chemoreceptor cells of the rabbit (Ca2+ currents) 
and in the secretory response elicited by high external K and hypoxia in in vitro CBs from 
rabbit and rat. 
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3. The Advances in the Cellular Physiology of the CB 1984–1988 with the Use of Veratridine, 
TTX, and Dihydropyridines 
Early in the introduction we referred to the names given to the CB in early times: all of them 
implying the small size of the organ (around 50, 350 and 500 µg in the rat, rabbit, and cat, 
respectively) and to the small size of chemoreceptor cells, ≤10 μm in diameter. To this it should be 
added that the CB is heterogeneous and contains several cell types with parenchymal chemoreceptor 
cells representing around 30% of the organ cells [4,53]. Obviously, this results in very poor yields of 
viable cells in early tentative dissociations and primary cultures of the CB; these facts, in turn, explain 
the running behind of the knowledge on CB cellular or general physiology. 
These facts explain why our dealing with the problem of sensory transduction was based on the use 
of a classical neurochemical-pharmacological approach, tightly adhered to the stimulus secretion 
coupling doctrine. Those facts also explain why we adhere to measure DA, the reason being that in the 
CB, DA was specifically located in chemoreceptor cells, and why we used isotopic methods that 
provided the highest sensitivity. To these facts we needed to add an additional one: the use of very 
specific pharmacological tools as we have described in preceding paragraphs. Many of these basic 
principles were learnt by one of us while a postdoc in SJ Fidone’s laboratory in Salt Lake City but 
were fully developed in our laboratory in Valladolid, although the path between Valladolid and Salt 
Lake City has remained and still remains well in use in both directions [54–56].  
Following experimental protocols used by Kirpekar and Garcia [57] we succeeded in demonstrating 
that nitrendipine greatly inhibited the release of DA induced by hypoxia in chemoreceptor cells and 
presented the findings in the VIIIth Meeting of the International Society for Arterial Chemoreception 
in the fall of 1985 [58–60]. During 1986, Rocher entered in our laboratory as a graduate student and 
quite soon she demonstrated that rabbit chemoreceptor cells were excitable in neurochemical-
pharmacological terms because quite early she demonstrated that veratridine induced a Na+ and Ca2+ 
dependent release of DA from rabbit chemoreceptor cells. She showed further that veratridine induced 
release was nearly abolished by TTX, and most important, that low PO2-induced release also was 
partially inhibited by TTX. Her findings were communicated in early in 1987 to the Spanish Society of 
Biophysics, published as a short note in 1988 and as full length paper in 1994 [61–63]. Table 1 
presents the status of our knowledge by the fall of 1987. 
To the data of Table 1, which refer to rabbit CB chemoreceptor cells, we should add that TTX did 
not affect normoxic, basal ongoing release of DA. It should also be noted from Table 1 that even if 
Na+ channels participate in the cascade of events that occurs between the low PO2 detection and the 
neurosecretory response [63], this participation represents an amplifying signal because an important 
part of the response (≈60%) still remains when Na+ channels are fully inhibited. Additionally, Table 1 
shows that the participation of dihydropyridine sensitive channels in the entry of Ca2+ to support 
hypoxia-induced release varies with the intensity of hypoxia, and finally, that even with mild hypoxia, 
some voltage-dependent pathways additional to L-type Ca2+ channels participate in the stimulus- secretion 
coupling, because at any given hypoxic intensity the evoked release of DA is Ca2+ dependent by more 
than 95%. Although chemoreceptor cells contain other neurotransmitters (ACh, ATP, opioid peptides, 
substance P, and probably others; [4]) that are known to be released by natural stimuli, we do not refer 
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to them in the present context because neither veratridine or TTX have been used in the 
characterization of their release process. 
Table 1. Neurochemical-pharmacological demonstration of the presence of  
voltage-dependent Na+ and L-type Calcium channels in chemoreceptor cells of freshly 
isolated rabbit carotid body. 
Incubating Conditions 
3H-CA Evoked Release 
(× Basal) 
% Change 
Veratridine (50 μM) 17.1 ± 0.9 --- 
Veratridine (50 μM) + TTX (1 μM) 0.3 ± 0.1 98 (inhibition) 
Veratridine (50 μM), Na+-free 0 100 (inhibition) 
Veratridine (50 μM), Ca2+-free 1.4 ± 0.3 92 (inhibition) 
Hypoxia (10 % O2) 2.8 ± 0.95 --- 
Hypoxia (10 % O2) + TTX (1 μM) 1.7 ± 0.3 40 (inhibition) 
Hypoxia (7% O2) 8.5 ± 2.2 --- 
Hypoxia (7% O2) + nisoldipine (0.625 μM) 1.9 ± 0.2 78 (inhibition) 
Hypoxia (2% O2) 28.6 ± 3.3 --- 
Hypoxia (2% O2) + nisoldipine (0.625 μM) 17.1 ± 0.9 41 (inhibition) 
Hypoxia (7% O2) + Bay K 8644 (1 μM) 31.2 ± 4.0 370 (potentiation) 
Experimental results shown in Table 1 clarify a point, namely, that hypoxia is capable of activating 
voltage dependent ion Na+ and Ca2+ channels (and probably also K+ channels), and therefore, hypoxia 
must depolarize chemoreceptor cells. The emerging question has conceptual and methodological 
implications: how does hypoxia depolarize chemoreceptor cells? What are the ionic conductances 
involved? Electrophysiological methods were needed to go deep into the sensory transduction 
mechanisms in chemoreceptor cells. Yet, we want to state that, when advisable and feasible, we have 
kept combining electrophysiology and neurochemistry in our experimental designs in order to obtain 
the unitary or nearly hints on the mechanisms involved and the integrated view of the neurosecretory 
response [51]. 
4. Direct Electrophysiological Assessment of the Presence of Voltage Operated Channels in 
Rabbit Chemoreceptor Cells. The Discovery of O2-Sentive or O2-Regulated Channels and the 
Hypoxic Transduction Cascade 
Classical intracellular recordings were extremely difficult due to the small size of the cells. As a 
consequence, the results they were yielding were difficult to interpret and conflicted with our own 
findings [3,64,65]. Therefore, it appeared that the electrophysiological approach to the problem of 
sensory transduction in the chemoreceptor cells of the CB must rely on the recently developed patch-clamp 
technique [66]. However, we had neither the technique, nor the very expensive equipment, nor the 
adequate preparation. Since we did not have the patch-clamp equipment or the expertise, after 
developing a primary culture of dissociated CB whose chemoreceptor cells retained functional 
properties in terms of metabolism of CA, we agreed on a collaboration with Lopez-Barneo in Sevilla, a 
well-established electrophysiologist. Several people from our laboratory spent almost the entire year of 
1987 going to the slaughter house to get calf CBs that would produce a yield of chemoreceptor cells 
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that we were able to isolate at near purity, in which we can measure ionic concentrations by flame 
photometry and the release of CA using radioisotopic method [67]. We switched to rabbit 
chemoreceptor cells and we obtained yields that we estimated adequate for the electrophysiological 
experiments. We succeeded and early in 1988, Lopez-Lopez travelled to Sevilla with required surgical 
instruments and enzyme batches and the recordings showed from the very first day that chemoreceptor 
cells were indeed excitable cells as they expressed Na+, Ca2+, and K+ voltage dependent currents. 
However, the resting Na+ conductance that we were hypothesizing that hypoxia would trigger/activate 
in accordance with the transduction in mechanoreceptors and the very recently described conductance 
gated by cAMP in olfactory receptors [68] was not there. The appearance in January 1988 of the paper 
by Avenet et al. [69] showing that sweet stimulus mediated increase in cAMP in taste receptor causes 
receptor depolarization via inhibition of K+ channels drove the attention to K+ currents and there it was: 
freshly isolated chemoreceptor cells of the rabbit CB have a component of their K+ currents that was 
reversibly inhibited by hypoxia [70]. Detailed characterization of the ionic currents in rabbit 
chemoreceptor cells appeared soon after in two full length studies [71,72]. In the decade that followed 
the initial description, several laboratories demonstrated the excitability of chemoreceptor cells in 
other species, e.g., [73,74]. All of them showed that, in addition to Ca2+ currents, chemoreceptor cells 
possess some component of their K+ conductances that was reversibly inhibited by hypoxia [73,74]. 
The presence of Na+ channels in rat chemoreceptor cells was a debated issue existing laboratories 
whose cells completely lack Na+ currents, while in others different percentages of cells expressed  
them [75]. Yet, it should be stated that Doyle and Donnelly [76] had reported that TTX inhibits by 
around 25% the release of CA elicited by anoxic stimuli. So the hypoxic sensory transduction process 
appeared as a simple cascade: hypoxia inhibits K+ currents and leads to chemoreceptor cell 
depolarization, activation of voltage dependent Ca2+ channels, and triggering the release of 
neurotransmitter that would drive sensory nerve endings of the CSN; activation of Na+ currents, if 
present, would amplify the signal to trigger Ca2+ channel opening. In more recent years, several 
laboratories have shown that mice chemoreceptor cells also possess some component of their Kv 
current that is reversibly inhibited by hypoxia [77,78], yet neither Na+ or Ca2+ currents have  
been described in the cells of this species. Surely we will undertake the more classical  
neurochemical-pharmacological approach to show if chemoreceptor cells naturally organized as they 
remain in the intact freshly isolated CBs have the channel armamentarium, defined with 
veratridine/TTX and dihydropyridine/conotoxins, as to generate inward currents.  
All the O2-sensitive currents so far described in chemoreceptor cells were voltage-dependent. This 
fact created a kind of muffled uneasiness: if the O2-sensitive currents are voltage-dependent it means 
that for them to become inhibited they must be activated by a prior depolarizing event. Gonzalez and 
co-workers [4,79] provided tentative and, might be imaginative answers, to this unsolved issue that, that 
we believe was experimentally resolved by Keith Buckler when, in 1997, he showed that rat 
chemoreceptor cells express, in addition to the O2-sensitive Ca2+ dependent K+ current described by 
Peers, a voltage independent leaky K+ current active at resting membrane potential and reversibly 
inhibited by hypoxia [80]. Today, it is our believe that it is almost universally accepted that this leaky 
current carried on by TASK-1, TASK-2, or TASK-3 homo or heteromerically assembled [81,82] is the 
trigger of the initial depolarization that would bring the membrane potential to the threshold for 
activation of voltage dependent channels. Yet, inhibition of O2 sensitive voltage-dependent K+ currents 
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would remain an absolute requirement for cell activation because outward currents, unless they are 
inhibited, exceed in amplitude inward currents and depolarization of the cells would not proceed [83,84].  
The next question is: what do ion channels have in chemoreceptor cells or what do chemoreceptor 
cells have to make some of their K+ channels O2-sensitve? Are channels themselves the O2-sensors? If 
yes, which are the channel domains or microdomains to give them the specificity of O2-sensors? And 
if no, what is the O2-sensor molecule present in chemoreceptor cells and functionally coupled to the  
O2-sensitive channels? Tentative, but not definitive, answers to these questions are beyond the present 
review and have been recently addressed by our and other laboratories [7,84–86]. 
5. The Significance of Na+ Channels in Rat Chemoreceptor Cell Responses to Hypoxia 
As mentioned above, controversies regarding the expression of Na+ channels in rat chemoreceptor 
cells using exclusively electrophysiological approaches and the absence of data in freshly isolated CB 
preparations drove us to study the potential significance of these ion channels in rat chemoreceptor 
cells using neurochemical, pharmacological and molecular biology approaches [87]. Voltage-gated 
sodium channels (Nav) are large glycoproteins consisting of three subunits, one α subunit and two β 
subunits (β1 and β2) [33]. The α subunit (≈220 kDa) forms the voltage-gated sodium selective aqueous 
pore and the β subunits modify channel properties and interact with cytoskeletal and extracellular 
matrix proteins. To date, at least nine different α subunits genes have been identified in mammals, 
named SCN1-11 [88,89]. Pharmacologically, Na+ channel isoforms are commonly distinguished by 
their sensitivity to TTX: most sodium channels are blocked by nanomolar (IC50 ≤ 20 nM) 
concentrations of TTX and are defined as TTX-sensitive (TTX-s) while others, requiring micromolar 
TTX (IC50 ≥ 0.5 µM) concentrations for their blockade, are defined as TTX-resistant channels  
(TTX-r) [27].  
We have used RT-PCR, immunoblotting, and immunocytochemical techniques to assess the 
presence of Na+ channels in the rat CB, to define their molecular identity and to locate them in 
chemoreceptor cells from adult rats. Additionally, we have used neurochemical and pharmacological 
techniques to define the functional significance of Na+ channels in the neurotransmitter release 
response to hypoxia from chemoreceptor cells in a preparation of freshly isolated intact rat CB. We 
have found that rat CB expresses five TTX-sensitive Nav isoforms detected by RT-PCR in total RNA 
extracted from the intact organ. We didn’t explore the presence of TTX resistant channels because the 
release 3H-CA elicited by veratridine was inhibited by in full in the intact organ by 1 µM TTX, as they 
did omission of Na+ and Ca2+ from the incubating solutions. In immunocytochemical and Western blot 
experiments, carried out, respectively, in frozen sections of the entire CB and crude homogenate of the 
intact organ and using a polyclonal antibody capable of reacting with a sequence common to all Nav α 
subunits, we provided unequivocal evidence for the presence of the conducting α subunit of Na+ 
channels in the TH-positive chemoreceptor cell clusters of the CB. Immunocytochemistry carried out 
in fresh cultured dissociated CB cells indicates that only the α subunits of Nav1.1, Nav1.3 and Nav1.6 
(the most abundant isoforms at the mRNA level) are indeed expressed in all TH-positive cells (Figure 3).  
In the experiments presented in our study with the intact preparation of the rat CB, we clearly 
showed that Na+ channels in chemoreceptor contribute by nearly 50% to the DA release response 
elicited by hypoxic stimuli of low intensity, and by a smaller percentage to the release response 
elicited by more intense hypoxia (Figure 3C); [76]. Although even in the most favorable 
Mar. Drugs 2011, 9                                       
 
2695
electrophysiological studies [90] the density of Na+ currents recorded from dissociated chemoreceptor 
cells is low in comparison to the density of Ca2+ currents, our data imply that Na+ currents contribute 
to increase the amplitude of the action potentials and therefore to the amount of Ca2+ entering the cells 
and to the magnitude of the Ca2+ dependent 3H-CA exocytosis. In this regard, Buckler and  
Vaughan-Jones [91] found that rat type I cells both under hypoxic stimulation can generate bursts of 
repetitive action potentials with clear overshoots suggestive of a contribution of Na+ currents in their 
genesis; higher overshoots are more evident in the action potentials generated by chemoreceptor cells 
cultured in hypoxia [92]. Interestingly, Buckler and Vaughan-Jones [93] observed a comparable 
spiking activity during hypercapnic stimulation of rat chemoreceptor cells, but TTX instead of 
producing the expected decrease in Ca2+ increase elicited by hypercapnia, caused a 50% increase in the 
Ca2+ response. This observation led them to conclude that, while the reason for this enhancement is not 
known, the result clearly shows that sodium-dependent action potentials are not required for the 
hypercapnic Ca2+ response [94]. 
In general, discrepancies in findings between our results and electrophysiological experiments 
could be explained by differences among studies using enzymatically dispersed cells and our 
preparation using mostly intact organs. Dissociation procedures involving enzymatic digestion for long 
periods of time can cause damage in α or β subunits of Na channels and be responsible for the different 
percentages of cells expressing Na+ currents, as it has been described in smooth muscle cells from 
mouse mesenteric artery [95]. 
Figure 3. Effect of tetrodotoxin (TTX) on the release of 3H-catecholamines evoked by 
veratridine and hypoxia in rat CB. (A) Time course of veratridine effect (50 μM) on 3H-CA 
release and TTX inhibition; (B) Veratridine and TTX effect on 3H-CA evoked release from 
normoxic and chronically hypoxic CBs; (C) Effect of TTX on release of 3H-catecholamines 
elicited by graded hypoxia. Bars represent ratios of total evoked release obtained with 
second stimulus challenge to that obtained with first one (S2/S1) for control (open bars) and 
TTX treated CBs during the second stimulus challenge (filled bars). Values are means ± SEM 
for 6–10 CBs. Statistically significant differences: * p < 0.05; ** p < 0.01. (Adapted  
from [87] with permission). 
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Figure 3. Cont. 
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6. Significance of Na+ Channels on Long Term Hypoxic Responses 
Chronic hypoxia (CH) enhances chemosensitivity in the CB and induces extensive and specific 
changes in gene expression including modifications in the rate of expression and regulation of K+ and 
Ca2+ channels, which are associated with O2-sensing and neurotransmitter release. In this regard, 
pioneer studies from Hempleman [96] and Nurse’s group [90,92] suggested that in vitro applied CH 
may increase chemoreceptor cells excitability by increasing the depolarizing sodium current. In our 
study we observed that after 7-day exposure of rats to normobaric hypoxia (10% O2), the CBs became 
hypertrophic (50% increased weight), store enhanced amounts of CA, express increased rate of 
synthesis, and exhibit exaggerated rate release of CA when challenged with veratridine (×5 release in 
CBs of control rats) and by acute hypoxia (×3 release in CBs of control rats). As in control animals, in 
CH animals veratridine-evoked secretion was dependent on the presence of Ca2+ and Na+ in the 
extracellular medium and was entirely blocked by 1 μM tetrodotoxin (TTX). Secretory response 
evoked by mild hypoxia (7% O2 during 10 min) retained the TTX-sensitivity seen in control animals, 
implying that functional adaptation of CB to chronic hypoxia in vivo, requires augmentation of Na+ 
channel expression to allow the enhanced functional requirements seen in more integrated responses 
such as increased neurotransmitter release (Figure 4). This higher concentration of neurotransmitter 
would at the end generate the sensitization of the CB to hypoxia seen in early weeks after sustained 
hypoxic exposure [97,98] evidenced by a higher frequency of action potentials in the CSN and the 
higher ventilatory response to acute hypoxic tests [98].  
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Figure 4. Expression of voltage-gated Na+ channel (Nav) in normoxic and chronically 
hypoxic rat CBs assessed by immunocitochemistry, Western Blot and RT-PCR.  
(A) Localization of Na+ channel isoforms Nav1.1, Nav1.3 and Nav1.6 by 
immunofluorescence in cultured rat chemoreceptor cells; (B) Representative immunoblot 
obtained from normoxic (CB-N; lanes 1–3) and chronic hypoxic (CB-CH; lanes 4–6) CBs 
homogenates fractionated on 8% SDS-polyacrilamide gel. Lanes 7 and 8 correspond to a 
positive control (superior cervical ganglion); (C) Agarose gel electrophoresis of different 
Nav channel genes (upper panels) and β-actin (lower panel; housekeeping gene) and 
tyrosine hydroxylase (TH). (Adapted from [87], with permission). 
 
 
7. Conclusions 
1. The carotid bodies were defined as arterial chemoreceptors around the 1930s, and by the 1970s 
most of the reflexes originated the carotid bodies had been defined. However, at the cellular level, 
these chemoreceptor organs remained mysterious. 
2. Since the structural organization of the carotid bodies is that of a secondary sensory receptor, it 
has been feasible to conceive the functioning of the organ within the frame of the stimulus-secretion 
concept: the natural stimuli to the receptors, hypoxia and hypercapnia, should elicit the release of 
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neurotransmitters from chemoreceptor cells that would generate the conducted activity in the sensory 
nerve innervating the organs to drive the reflexes. 
3. Based on this basic conception we started to measure the release of neurotransmitters elicited by 
natural stimuli and, using the adequate tools, we were able to define the basic mechanisms present in 
chemoreceptor cells and activated by different stimuli.  
4. Tetrodotoxin, veratridine and dihydropyridines proved to be basic and indispensable tools that 
allowed us to define chemoreceptor cells as excitable cells, and further to define that hypoxia 
depolarized the cells to generate the release of neurotransmitters conforming the most orthodox 
stimulus secretion coupling process. 
5. The development of a primary culture of chemoreceptor cells and the application of patch-clamp 
techniques confirmed the observations, and allowed to discover the existence of K+ channels in 
chemoreceptor cells reversibly inhibited by hypoxia, implying that they were primary elements in the 
genesis of the chemoreceptor cells depolarization. 
6. These results generated in the second half of the 1980 decade working with rabbit CBs have in 
more recent years been extended to all mammalian species studied.  
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